A citation-based method for searching scientific literature

Emanuela Minna, Paola Romeo, Matteo Dugo, Loris De Cecco, Antonella Aiello, Federico Pistore, Andrea Carenzo, Angela Greco, Maria Grazia Borrello. Cancers (Basel) 2022
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Multiple ETS Factors Participate in the Transcriptional Control of TERT Mutant Promoter in Thyroid Cancers.
Caitlin E M Thornton, Jingzhu Hao, Prasanna P Tamarapu, Iñigo Landa. Cancers (Basel) 2022
1
100

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas.
Meihua Jin, Dong Eun Song, Jonghwa Ahn, Eyun Song, Yu-Mi Lee, Tae-Yon Sung, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon,[...]. Cancers (Basel) 2021
6
50

RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient.
Rozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, Brian P Danysh, Kurt W Evans, Tyler J Moss, Argun Akcakanat, Patrick K S Ng, Christina M Knippler, Jalyn A Golden,[...]. Cancers (Basel) 2021
3
50

Development of Novel Follicular Thyroid Cancer Models Which Progress to Poorly Differentiated and Anaplastic Thyroid Cancer.
Caitlin O Caperton, Lee Ann Jolly, Nicole Massoll, Andrew J Bauer, Aime T Franco. Cancers (Basel) 2021
2
50

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy,[...]. J Clin Endocrinol Metab 2014
334
50

Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?
Cesar Seigi Fuziwara, Diego Claro de Mello, Edna Teruko Kimura. Cancers (Basel) 2022
1
100


Secreted Factors by Anaplastic Thyroid Cancer Cells Induce Tumor-Promoting M2-like Macrophage Polarization through a TIM3-Dependent Mechanism.
Cinthia Carolina Stempin, Romina Celeste Geysels, Sunmi Park, Luz Maria Palacios, Ximena Volpini, Claudia Cristina Motran, Eva Virginia Acosta Rodríguez, Juan Pablo Nicola, Sheue-Yann Cheng, Claudia Gabriela Pellizas,[...]. Cancers (Basel) 2021
5
50

APOBEC SBS13 Mutational Signature-A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma.
Sarah Siraj, Tariq Masoodi, Abdul K Siraj, Saud Azam, Zeeshan Qadri, Sandeep K Parvathareddy, Rong Bu, Khawar S Siddiqui, Saif S Al-Sobhi, Mohammed AlDawish,[...]. Cancers (Basel) 2022
2
50

MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression.
Danny Misiak, Marcus Bauer, Jana Lange, Jacob Haase, Juliane Braun, Kerstin Lorenz, Claudia Wickenhauser, Stefan Hüttelmaier. Cancers (Basel) 2021
2
50



Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes.
Miriam Steinschneider, Jacob Pitaro, Shlomit Koren, Yuval Mizrakli, Carlos Benbassat, Limor Muallem Kalmovich. Cancers (Basel) 2021
4
50

Biologic and Clinical Perspectives on Thyroid Cancer.
James A Fagin, Samuel A Wells. N Engl J Med 2016
421
50

Radio-Iodide Treatment: From Molecular Aspects to the Clinical View.
Antonio De la Vieja, Garcilaso Riesco-Eizaguirre. Cancers (Basel) 2021
11
50

Annual Hazard Rate of Recurrence in Middle Eastern Papillary Thyroid Cancer over a Long-Term Follow-Up.
Abdul K Siraj, Sandeep Kumar Parvathareddy, Zeeshan Qadri, Khawar Siddiqui, Saif S Al-Sobhi, Fouad Al-Dayel, Khawla S Al-Kuraya. Cancers (Basel) 2020
9
50

Evidence of Cooperation between Hippo Pathway and RAS Mutation in Thyroid Carcinomas.
Thaise Nayane Ribeiro Carneiro, Larissa Valdemarin Bim, Vanessa Candiotti Buzatto, Vanessa Galdeno, Paula Fontes Asprino, Eunjung Alice Lee, Pedro Alexandre Favoretto Galante, Janete Maria Cerutti. Cancers (Basel) 2021
2
50


Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
560
50

Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma.
Antónia Afonso Póvoa, Elisabete Teixeira, Maria Rosa Bella-Cueto, Rui Batista, Ana Pestana, Miguel Melo, Thalita Alves, Mafalda Pinto, Manuel Sobrinho-Simões, Jorge Maciel,[...]. Cancers (Basel) 2021
4
50

Translational Utility of Liquid Biopsies in Thyroid Cancer Management.
Ayanthi A Wijewardene, Marthe Chehade, Matti L Gild, Roderick J Clifton-Bligh, Martyn Bullock. Cancers (Basel) 2021
2
50

Medullary Thyroid Carcinoma: An Update on Imaging.
Sergiy V Kushchayev, Yevgeniya S Kushchayeva, Sri Harsha Tella, Tetiana Glushko, Karel Pacak, Oleg M Teytelboym. J Thyroid Res 2019
27
50

Comparing intraoperative parathyroid identification based on surgeon experience versus near infrared autofluorescence detection - A surgeon-blinded multi-centric study.
Giju Thomas, Carmen C Solórzano, Naira Baregamian, Emmanuel A Mannoh, Rekha Gautam, Rebecca T Irlmeier, Fei Ye, Jon A Nelson, Samuel E Long, Paul G Gauger,[...]. Am J Surg 2021
6
50

Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial.
Dapeng Li, Yihebali Chi, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng,[...]. Clin Cancer Res 2021
16
50

Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.
C M Thomas, S L Asa, S Ezzat, A M Sawka, D Goldstein. Curr Oncol 2019
28
50

Complications after total thyroidectomy.
N Christou, M Mathonnet. J Visc Surg 2013
86
50

Current state of intraoperative use of near infrared fluorescence for parathyroid identification and preservation.
Carmen C Solórzano, Giju Thomas, Eren Berber, Tracy S Wang, Gregory W Randolph, Quan-Yang Duh, Frédéric Triponez. Surgery 2021
25
50

Lenvatinib: Role in thyroid cancer and other solid tumors.
Maria E Cabanillas, Mouhammed Amir Habra. Cancer Treat Rev 2016
100
50

Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches.
Caroline Bodet-Milin, Clément Bailly, Yann Touchefeu, Eric Frampas, Mickael Bourgeois, Aurore Rauscher, Franck Lacoeuille, Delphine Drui, Nicolas Arlicot, David M Goldenberg,[...]. Front Med (Lausanne) 2019
10
50

Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment.
L Fugazzola, M Di Stefano, S Censi, A Repaci, C Colombo, F Grimaldi, F Magri, U Pagotto, M Iacobone, L Persani,[...]. J Endocrinol Invest 2021
12
50

Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy.
Erika Grossrubatscher, Giuseppe Fanciulli, Luca Pes, Franz Sesti, Carlotta Dolci, Federica de Cicco, Annamaria Colao, Antongiulio Faggiano, Nike Group. J Clin Med 2020
12
50


A primer on the genetics of medullary thyroid cancer.
V Larouche, A Akirov, C M Thomas, M K Krzyzanowska, S Ezzat. Curr Oncol 2019
11
50

Intraoperative Indocyanine Green (ICG) Angiography for the Identification of the Parathyroid Glands: Current Evidence and Future Perspectives.
Eleftherios Spartalis, Georgios Ntokos, Konstantinos Georgiou, Georgios Zografos, Gerasimos Tsourouflis, Dimitrios Dimitroulis, Nikolaos I Nikiteas. In Vivo 2020
31
50


Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
A L Mitchell, A Gandhi, D Scott-Coombes, P Perros. J Laryngol Otol 2016
98
50

Risk Factors for Lateral Lymph Node Metastases in Patients With Sporadic Medullary Thyroid Carcinoma.
Xin Wu, Binglu Li, Chaoji Zheng, Wei Liu, Tao Hong, Xiaodong He. Technol Cancer Res Treat 2020
4
50

Update on Targeted Therapy in Medullary Thyroid Cancer.
Christian Okafor, Julie Hogan, Margarita Raygada, Barbara J Thomas, Srivandana Akshintala, John W Glod, Jaydira Del Rivero. Front Endocrinol (Lausanne) 2021
5
50

Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4.
Vijay G Bhoj, Lucy Li, Kalpana Parvathaneni, Zheng Zhang, Stephen Kacir, Dimitrios Arhontoulis, Kenneth Zhou, Bevin McGettigan-Croce, Selene Nunez-Cruz, Gayathri Gulendran,[...]. Mol Ther Oncolytics 2021
8
50

Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
Sergio Di Molfetta, Andrea Dotto, Giuseppe Fanciulli, Tullio Florio, Tiziana Feola, Annamaria Colao, Antongiulio Faggiano. Front Endocrinol (Lausanne) 2021
7
50

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Rossella Elisei, Valeria Bottici, Fabiana Luchetti, Giancarlo Di Coscio, Cristina Romei, Lucia Grasso, Paolo Miccoli, Pietro Iacconi, Fulvio Basolo, Aldo Pinchera,[...]. J Clin Endocrinol Metab 2004
286
50

Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Zubair W Baloch, Sylvia L Asa, Justine A Barletta, Ronald A Ghossein, C Christofer Juhlin, Chan Kwon Jung, Virginia A LiVolsi, Mauro G Papotti, Manuel Sobrinho-Simões, Giovanni Tallini,[...]. Endocr Pathol 2022
26
50

Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
Carrie C Lubitz, Peter M Sadow, Gilbert H Daniels, Lori J Wirth. Thyroid 2021
6
50

Clinical impact of 68Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer.
Murat Tuncel, Saadettin Kılıçkap, Nilda Süslü. Ann Nucl Med 2020
7
50

State-of-the-Art Strategies for Targeting RET-Dependent Cancers.
Vivek Subbiah, Dong Yang, Vamsidhar Velcheti, Alexander Drilon, Funda Meric-Bernstam. J Clin Oncol 2020
81
50

Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
Lindsay Brammen, Martin B Niederle, Philipp Riss, Christian Scheuba, Andreas Selberherr, Georgios Karanikas, Gerd Bodner, Oskar Koperek, Bruno Niederle. Ann Surg Oncol 2018
20
50

Analogs of the Heat Shock Protein 70 Inhibitor MKT-077 Suppress Medullary Thyroid Carcinoma Cells.
Seung-Keun Hong, Dmytro Starenki, Oleta T Johnson, Jason E Gestwicki, Jong-In Park. Int J Mol Sci 2022
2
50

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
S Filetti, C Durante, D Hartl, S Leboulleux, L D Locati, K Newbold, M G Papotti, A Berruti. Ann Oncol 2019
241
50

Intraoperative Autofluorescence and Indocyanine Green Angiography for the Detection and Preservation of Parathyroid Glands.
Marco Stefano Demarchi, Wolfram Karenovics, Benoît Bédat, Frédéric Triponez. J Clin Med 2020
26
50

Lymph Node Metastases of Medullary Thyroid Cancer: Role of Calcitonin in the Washout Fluid of Fine-Needle Aspiration.
Bernardo Marques, Nuno Cunha, Raquel G Martins, Ana Rita Elvas, Joana Couto, Jacinta Santos, Teresa Martins, Ana Paula Moniz, Olga Ilhéu, Frederico Valido,[...]. Int J Endocrinol 2020
5
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.